Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precision Biosciences Inc (DTIL)

Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Precision Biosciences Inc 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 USA

www.precisionbiosciences.com Employees: 108 P: 919-314-5512 F: 480-393-5553

Sector:

Medical

Description:

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 105,560
Enterprise Value, $K 41,980
Shares Outstanding, K 22,898
Float, K 21,868
% Float 95.50%
Short Interest, K 1,484
Short Float 6.48%
Days to Cover 6.41
Short Volume Ratio 0.44
% of Insider Shareholders 4.50%
% of Institutional Shareholders 37.99%

Financials:

Annual Sales, $ 68,700 K
Annual Net Income, $ 7,170 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -21,770 K
EBIT, $ -89,510 K
EBITDA, $ -85,630 K

Growth:

1-Year Return -9.07%
3-Year Return -81.95%
5-Year Return -98.58%
5-Year Revenue Growth 208.90%
5-Year Earnings Growth 94.32%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.84 on 11/03/25
Next Earnings Date 03/25/26 [--]
Earnings Per Share ttm -9.38
EPS Growth vs. Prev Qtr 13.62%
EPS Growth vs. Prev Year 34.98%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/14/24

DTIL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -233.77%
Return-on-Assets % -78.93%
Profit Margin % 10.44%
Debt/Equity 1.35
Price/Sales 67.80
Price/Cash Flow N/A
Price/Book 3.61
Book Value/Share 1.25
Interest Coverage 5.03
60-Month Beta 1.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar